Inferno
Inferno, licence 80096258: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Wilshire Labs Private Limited
- NPN or DIN-HM
- 80096258
- Status
- Active licence
- Licence date
- 24 December 2019
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Achillea millefolium Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 750 mg | 75.0 mg | Not calculated |
| Lepidium meyenii Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1000 mg | 100.0 mg | Not calculated |
| Acide 2-aminoéthanesulfonique Source : Taurine | 50.0 mg | Not calculated |
Non-medicinal ingredients
Lécithine, Alcool isopropylique, Lactose, Vanilline, Gomme de xanthane, Dioxyde de titane, Amidon de maïs, Laque d'aluminium jaune de quinoléine (E104), Hydroxypropylméthylcellulose, C.I. n° 45430, Stéarate de magnésium, Talcum, Poly(alcool vinylique), Poly(éthylène glycol), Cellulose microcristalline, Glycolate d'amidon sodique, Laque d'aluminium - carmin d'indigo
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 3.0 Comprimé | 1.0 Tous les jours |
Uses authorised in Canada
L-Arginine is (a non-essential amino acid) involved in protein synthesis. Source of/Provides antioxidants. Helps to support emotional aspects of sexual health. Helps to support healthy mood balance during menopause. Traditionally used in Ayurveda as Vrsya (aphrodisiac) for men.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80096258
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.